EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy

Vasco Sequeira, Lili Wang, Paul J M Wijnker, Kyungsoo Kim, Jose R Pinto, Cris Dos Remedios, Charles Redwood, Bjorn C Knollmann, Jolanda van der Velden

Journal of Molecular and Cellular Cardiology Plus · 2022

DOI: 10.1016/j.jmccpl.2022.100007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular and Cellular Cardiology Plus, 2022. Verfasst von Vasco Sequeira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Vrije Universiteit Amsterdam, Physiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NWO Earth and Life Sciences, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tissue and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to gain insight into how the balance between mutant and WT protein expression affects cardiomyocyte function.

Methods

Force measurements were performed in cardiomyocytes isolated from a HCM patient carrying a homozygous troponin T mutation (cTnT-K280N) and healthy donors. To discriminate between mutation-mediated and phosphorylation-related effects on Ca2+-sensitivity, cardiomyocytes were treated with alkaline phosphatase (AP) or protein kinase A (PKA). Troponin exchange experiments characterized the relation between mutant levels and myofilament function. To define mutation-mediated effects on Ca2+-dynamics we used CRISPR/Cas9 to generate hiPSC-CMs harbouring heterozygous and homozygous TnT-K280N mutations. Ca2+-transient and cell shortening experiments compared these lines against isogenic controls.

Results

Myofilament Ca2+-sensitivity was higher in homozygous cTnT-K280N cardiomyocytes and was not corrected by AP- and PKA-treatment. In cTnT-K280N cells exchanged with cTnT-WT, a low level (14%) of cTnT-K280N mutation elevated Ca2+-sensitivity. Similarly, exchange of donor cells with 45 ± 2% cTnT-K280N increased Ca2+-sensitivity and was not corrected by PKA. cTnT-K280N hiPSC-CMs show elevated diastolic Ca2+ and increases in cell shortening. Impaired cardiomyocyte relaxation was only evident in homozygous cTnT-K280N hiPSC-CMs.

Conclusions

The cTnT-K280N mutation increases myofilament Ca2+-sensitivity, elevates diastolic Ca2+, enhances contractility and impairs cellular relaxation. A low level (14%) of the cTnT-K280N sensitizes myofilaments to Ca2+, a universal finding of human HCM.

Schlagwörter

Stichwörter der Autor:innen

Hypertrophic cardiomyopathyMyofilament Ca2+-sensitivityProtein toxic thresholdTroponin ThiPSC-CM

Autor:innen und Institutionen

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Physiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Netherlands Heart Institute, Utrecht, the Netherlands.
  • Division of Clinical Pharmacology, Vanderbilt School of Medicine, Nashville, United States.
  • Comprehensive Heart Failure Center (CHFC) University Clinic Würzburg, Würzburg, Germany.
  • Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL, USA.
  • Muscle Research Unit, Discipline of Anatomy & Histology, Bosch Institute, The University of Sydney, Sydney, Australia.

Förderung

  • NHLBI NIH HHS
  • NWO Earth and Life Sciences
  • European Commission
  • National Institutes of Health
  • Hartstichting
  • American Heart Association
  • Seventh Framework Programme
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Sequeira, V., Wang, L., Wijnker, P. J. M., Kim, K., Pinto, J. R., Dos Remedios, C., Redwood, C., Knollmann, B. C., & van der Velden, J. (2022). Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy. Journal of Molecular and Cellular Cardiology Plus. https://doi.org/10.1016/j.jmccpl.2022.100007

Vancouver

Sequeira V, Wang L, Wijnker PJM, Kim K, Pinto JR, Dos Remedios C, et al. Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy. Journal of Molecular and Cellular Cardiology Plus. 2022. doi:10.1016/j.jmccpl.2022.100007

BibTeX
@article{Sequeira2022,
  author = {Sequeira, Vasco and Wang, Lili and Wijnker, Paul J M and Kim, Kyungsoo and Pinto, Jose R and Dos Remedios, Cris and Redwood, Charles and Knollmann, Bjorn C and van der Velden, Jolanda},
  title = {Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy},
  journal = {Journal of Molecular and Cellular Cardiology Plus},
  year = {2022},
  doi = {10.1016/j.jmccpl.2022.100007}
}
Kostenlos starten →